Identified factors are called predictive biomarkers or theranostic biomarkers and are used extensively in the cancer therapeutic field; for example, expression of the estrogen receptor (ER) gene predicts response to tamoxifen in patients with breast cancer and such tests are used routinely to help select the most appropriate treatments for individual patients [6]. This evidence concerns the gene ESR1 and cancer.